Advancing Extracellular Vesicle Therapeutics into Clinical Trials for Central Nervous System Disorders
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2024, Vol 5, Issue 1
Abstract
In December 2023, the US Food and Drug Administration released a draft guidance document titled “Potency Assurance for Cellular and Gene Therapy Products Draft Guidance for Industry” for public comment [1]. Potency assays are arguably the most problematic analytic release assay to develop for cell and cell derivate products, including Extracellular Vesicles (EV). EVs are produced by many cell types and harbor parent cell-specific bioactive cargoes including proteins and nucleic acids. They are unique intercellular signaling particles that can act as both the messenger and/or effector in recipient cells. We and others have shown that Neural Stem Cell EVs (NSC EVs) derived in bioreactors have therapeutic potential for treating neurological disease and Acute Ischemic Stroke (AIS). New FDA Investigational New Drug (IND) applications are being filed and specifically, we have an IND application for AIS. As the field grows, new INDs will be filed for various other therapeutic indications. In order for EV therapeutics to move efficiently through the regulatory process to approval, there is a need for more emphasis on and development of analytical assays directly related to complex and likely multimodal, mechanisms of action. Research focused on this area will lead to new disease-specific potency assays and identification of critical quality attributes.
Authors and Affiliations
Steven L Stice, Emily W Baker, Viviana Martinez Hamilton, Raymond L Swetenburg
Keywords
Related Articles
- EP ID EP729623
- DOI https://doi.org/10.46889/JRMBR.2024.5101
- Views 21
- Downloads 1
The Applications of Human Umbilical Cord Mesenchymal Stem Cells to Treat Spinal Cord Injuries
Due to the morbidity and resulting lifestyle changes of Spinal Cord Injuries (SCI), there has been an extensive need to evaluate potential treatments. Mesenchymal cells hold the capacity to address both the primary and s...
Use of Circularly Polarized Light on the Evaluation of Injectable Platelet Rich Fibrin in the Early Formation of Woven and Lamellar Bone: A Specific Method in the Study of Osseous Tissue
Purpose: In bone grafting, the goal is the formation of 100% vital bone. The ideal graft material is osteogenic, osteoconductive and osteoinductive and can be evaluated by histology and histomorphometric methods to calcu...
Stem Cell Therapies in Systemic Sclerosis: An Updated Review
Systemic sclerosis systemic is a systemic autoimmune disease that ultimately leads to severe damage and failure of multiple body organs. The disease is associated with significant morbidity and mortality as well as poo...
Patch Repair for Intestinal Perforation Closure in an Ex-Vivo Porcine Model with Burst Pressure Characterization
Background: Bowel perforation is the loss of intestinal wall integrity and can occur by several mechanisms including infection, obstruction, inflammation, trauma and iatrogenic causes. Incidences of bowel perforation ran...
Numerous Types of Stem Cells Possess Potential to Treat Congenital Hydrocephalus
Twenty-five percent of premature neonate’s experience Intraventricular Hemorrhage (IVH) and 10% of these events are complicated further by the occurrence of hydrocephalus. The number of infants at high risk for IVH and t...